Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.

Halbrook M, Merritt S, Hoff NA, Mukadi P, Kompany JP, Musene K, Beya M, Kalengi H, Tambu M, Kelly JD, Ball AH, To A, MacGill T, Orr R, Myers T, Woods CW, Nicholson BP, Wong TA, Hensley LE, Kindrachuk J, Lehrer AT, Mbala-Kingebeni P, Rimoin AW.

Open source

DOI
10.1016/s0140-6736(26)01608-9
Published
2026-08-25
Container
Lancet
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-26-01608-9,
  title = {Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.},
  author = {Halbrook M and  Merritt S and  Hoff NA and  Mukadi P and  Kompany JP and  Musene K and  Beya M and  Kalengi H and  Tambu M and  Kelly JD and  Ball AH and  To A and  MacGill T and  Orr R and  Myers T and  Woods CW and  Nicholson BP and  Wong TA and  Hensley LE and  Kindrachuk J and  Lehrer AT and  Mbala-Kingebeni P and  Rimoin AW.},
  year = {2026},
  journal = {Lancet},
  doi = {10.1016/s0140-6736(26)01608-9},
  url = {https://doi.org/10.1016/s0140-6736(26)01608-9}
}

RIS

TY  - JOUR
TI  - Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.
AU  - Halbrook M
AU  -  Merritt S
AU  -  Hoff NA
AU  -  Mukadi P
AU  -  Kompany JP
AU  -  Musene K
AU  -  Beya M
AU  -  Kalengi H
AU  -  Tambu M
AU  -  Kelly JD
AU  -  Ball AH
AU  -  To A
AU  -  MacGill T
AU  -  Orr R
AU  -  Myers T
AU  -  Woods CW
AU  -  Nicholson BP
AU  -  Wong TA
AU  -  Hensley LE
AU  -  Kindrachuk J
AU  -  Lehrer AT
AU  -  Mbala-Kingebeni P
AU  -  Rimoin AW.
PY  - 2026
JO  - Lancet
DO  - 10.1016/s0140-6736(26)01608-9
UR  - https://doi.org/10.1016/s0140-6736(26)01608-9
ER  - 

APA

M, H., S, M., NA, H., P, M., JP, K., K, M., M, B., H, K., M, T., JD, K., AH, B., A, T., T, M., R, O., T, M., CW, W., BP, N., TA, W., LE, H., J, K., AT, L., P, M., & AW., R. (2026). Bundibugyo virus glycoprotein seroreactivity following recombinant vesicular stomatitis virus-Zaire Ebola virus glycoprotein vaccination in outbreak-affected populations of the Democratic Republic of the Congo: a longitudinal cohort study.. Lancet. https://doi.org/10.1016/s0140-6736(26)01608-9

Source records